Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial-Reference-Cited by-同舟云学术

Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial

Published:2023-07 Issue:1 Volume:84 Page:95-108
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Grivas Petros,Park Se Hoon,Voog Eric,Caserta Claudia,Gurney Howard,Bellmunt Joaquim,Kalofonos Haralabos,Ullén Anders,Loriot Yohann,Sridhar Srikala S.,Yamamoto Yoshiaki,Petrylak Daniel P.,Sternberg Cora N.,Gupta Shilpa,Huang Bo,Costa Nuno,Laliberte Robert J.,di Pietro Alessandra,Valderrama Begoña P.,Powles Thomas

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma;Powles;N Engl J Med,2020

2. Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): long-term follow-up results from the JAVELIN Bladder 100 trial;Powles;J Clin Oncol,2022

3. NCCN Clinical practice guidelines in oncology: bladder cancer v2.2022;National Comprehensive Cancer Network,2022

4. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Powles;Ann Oncol,2022

5. The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma;Cathomas;Eur Urol,2021

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives;International Journal of Molecular Sciences;2024-09-07

2. Paradigmenwechsel in der Systemtherapie des metastasierten Urothelkarzinoms – Antikörper-Wirkstoff-Konjugate (ADC) und FGFR-Inhibitoren („fibroblast growth factor rezeptor“);Die Urologie;2024-09-05

3. Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer;European Urology;2024-09

4. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

5. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18